foods not to eat on semaglutide Avoid foods to stay away from

The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2

Why Choose IV Drip Therapy

Recommended Use: For novices: Take 1 capsule daily with breakfast

Cost and insurance coverage remain major barriers to widespread use of GLP-1 receptor agonists in HS, as this is currently an off-label indication

Mintziori G, Mousiolis A, Duntas LH, Goulis DG